Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 4, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.63B
sum of reported positions
Reported positions
182
Changes vs prior quarter
117
10 new · 7 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 324 measured positions in 8 quarters, the typical new or larger position finished −2.6 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 307K | $133M | 2.4% | |
TEVA PHARMACEUTICAL INDS LTD | 3.79M | $128M | 2.3% |
| 371K | $126M | 2.2% | |
| 417K | $117M | 2.1% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.11B | $5.63B |
| Positions | 179 | 182 |
| Biggest line | — | Dell Technologies 2% |
| 361K | $109M | 1.9% |
| 218K | $104M | 1.9% |
| 256K | $91.5M | 1.6% |
| 6.51M | $89.9M | 1.6% |
| 2.73M | $85.8M | 1.5% |
| 1.1M | $85.6M | 1.5% |
| 877K | $83.2M | 1.5% |
| 1.04M | $80.9M | 1.4% |
| 5.35M | $80.5M | 1.4% |
| 4.03M | $80.1M | 1.4% |
| 383K | $80.1M | 1.4% |
| 244K | $79.9M | 1.4% |
| 200K | $76.9M | 1.4% |
| 200K | $75.4M | 1.3% |
| 1.07M | $75.3M | 1.3% |
| 517K | $75.3M | 1.3% |
| 66K | $74.6M | 1.3% |
| 104K | $74.3M | 1.3% |
| 2.68M | $72M | 1.3% |
| 282K | $71.1M | 1.3% |
| 62K | $71M | 1.3% |
Dell Technologies (DELL)
345K → 307K shares (−11%)
Jabil (JBL)
221K → 200K shares (−10%)
Broadcom (AVGO)
219K → 200K shares (−9%)
Aercap Holdings (AER)
530K → 517K shares (−3%)
Cummins (CMI)
122K → 104K shares (−15%)
Barclays (BCS)
2.9M → 2.68M shares (−7%)
Micron (MU)
81K → 62K shares (−24%)
Cisco (CSCO)
808K → 586K shares (−28%)
Qualcomm (QCOM)
382K → 372K shares (−3%)
Medtronic (MDT)
930K → 849K shares (−9%)
HCA Healthcare (HCA)
167K → 162K shares (−3%)
Kb Financial Group (KB)
557K → 551K shares (−1%)
Gilead Sciences (GILD)
578K → 422K shares (−27%)
Kroger (KR)
1.02M → 935K shares (−8%)
Novartis (NVS)
432K → 317K shares (−27%)
Amgen (AMGN)
128K → 108K shares (−16%)
Akamai Technologies (AKAM)
473K → 319K shares (−33%)
Smith & Nephew (SNN)
1.39M → 1.25M shares (−10%)
NetApp (NTAP)
240K → 217K shares (−10%)
DaVita (DVA)
223K → 147K shares (−34%)
Alibaba Group Holding (BABA)
404K → 321K shares (−21%)
State Street Corporation (STT)
192K → 173K shares (−10%)
Sanofi (SNY)
683K → 674K shares (−1%)
MGM Resorts (MGM)
685K → 599K shares (−12%)
Globe Life (GL)
183K → 159K shares (−14%)
